The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly

Danny Ulahannan, Adrian WaggDepartment of Geriatric Medicine, University College Hospital, London, UKAbstract: After lifestyle and behavioral measures to control overactive bladder, the mainstay of pharmacological treatment is the use of antimuscarinic therapy. Overactive bladder predominantly affec...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Danny Ulahannan, Adrian Wagg
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	overactive bladder tolterodine urgency incontinence Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/7ecdbb11e6b34920961bfaa4c66f2845
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7ecdbb11e6b34920961bfaa4c66f2845
record_format	dspace
spelling	oai:doaj.org-article:7ecdbb11e6b34920961bfaa4c66f28452021-12-02T04:07:46ZThe safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly1178-1998https://doaj.org/article/7ecdbb11e6b34920961bfaa4c66f28452009-04-01T00:00:00Zhttps://www.dovepress.com/the-safety-and-efficacy-of-tolterodine-extended-release-in-the-treatme-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Danny Ulahannan, Adrian WaggDepartment of Geriatric Medicine, University College Hospital, London, UKAbstract: After lifestyle and behavioral measures to control overactive bladder, the mainstay of pharmacological treatment is the use of antimuscarinic therapy. Overactive bladder predominantly affects older people, who experience the most severe disease, and are also at a greater risk of side effects from antimuscarinic therapy. Thus it is imperative that data are available on the efficacy and tolerability of this group of drugs when used in older people. This article reviews the pathophysiology of the condition, its effect on the elderly and the evidence for the use of extended release tolterodine in the elderly using data from placebo and active drug controlled studies.Keywords: overactive bladder, tolterodine, urgency incontinenceDanny UlahannanAdrian WaggDove Medical Pressarticleoveractive bladdertolterodineurgency incontinenceGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 4, Pp 191-196 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	overactive bladder tolterodine urgency incontinence Geriatrics RC952-954.6
spellingShingle	overactive bladder tolterodine urgency incontinence Geriatrics RC952-954.6 Danny Ulahannan Adrian Wagg The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
description	Danny Ulahannan, Adrian WaggDepartment of Geriatric Medicine, University College Hospital, London, UKAbstract: After lifestyle and behavioral measures to control overactive bladder, the mainstay of pharmacological treatment is the use of antimuscarinic therapy. Overactive bladder predominantly affects older people, who experience the most severe disease, and are also at a greater risk of side effects from antimuscarinic therapy. Thus it is imperative that data are available on the efficacy and tolerability of this group of drugs when used in older people. This article reviews the pathophysiology of the condition, its effect on the elderly and the evidence for the use of extended release tolterodine in the elderly using data from placebo and active drug controlled studies.Keywords: overactive bladder, tolterodine, urgency incontinence
format	article
author	Danny Ulahannan Adrian Wagg
author_facet	Danny Ulahannan Adrian Wagg
author_sort	Danny Ulahannan
title	The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
title_short	The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
title_full	The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
title_fullStr	The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
title_full_unstemmed	The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
title_sort	safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
publisher	Dove Medical Press
publishDate	2009
url	https://doaj.org/article/7ecdbb11e6b34920961bfaa4c66f2845
work_keys_str_mv	AT dannyulahannan thesafetyandefficacyoftolterodineextendedreleaseinthetreatmentofoveractivebladderintheelderly AT adrianwagg thesafetyandefficacyoftolterodineextendedreleaseinthetreatmentofoveractivebladderintheelderly AT dannyulahannan safetyandefficacyoftolterodineextendedreleaseinthetreatmentofoveractivebladderintheelderly AT adrianwagg safetyandefficacyoftolterodineextendedreleaseinthetreatmentofoveractivebladderintheelderly
_version_	1718401439961710592

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly

Ejemplares similares